4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc.

World Rank (Jan-05-2024)
9,373
Market Cap (Jan-05-2024)
0.862 Billion USD
World Rank (Jul-30-2023)
10,151
Market Cap (Jul-30-2023)
0.768 Billion USD
World Rank (Jan-07-2022)
12,298
Market Cap (Jan-07-2022)
0.603 Billion USD
World Rank (Jan-01-2021)
7,586
Market Cap (Jan-01-2021)
1.098 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
FDMT
Market Cap (Mar-08-2026)
0.49
Employee Count
78
Employee Count as of Date
As on September-2020
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
3 Million USD
Annual Operating Income in USD
-110 Million USD
Annual Net Income in USD
-107 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
261 Million USD
Total Liabilities in USD
31 Million USD
Total Equity in USD
231 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
4D MOLECULAR THERAPEUTICS INC.
Company Profile
4D Molecular Therapeutics is an Innovative Gene Therapy company designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions. The company annual revenue is 6.99 million USD and 78 employees as on 2019. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share